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Synthetic smooth muscle cell phenotype is
associated with increased nicotinamide adenine
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on collagen secretion
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Objective: Smooth muscle cells (SMCs) from prosthetic vascular grafts secrete higher levels of collagen than aortic SMCs
under basal conditions and during incubation with oxidized low-density lipoprotein. We postulated that reactive oxygen
species (ROS) contributed to the observed difference. The objective of this study was to assess the effect of ROS on
collagen secretion by aortic and graft SMCs and explore the mechanism involved.
Methods: SMCs isolated from canine aorta or Dacron thoracoabdominal grafts were incubated with 6-anilinoquinoline-
5,8-quinone (LY83583), an agent that induces superoxide production. Type I collagen in the conditioned medium was
measured by enzyme-linked immunosorbent assay, and superoxide anion production was measured by lucigenin assay.
Results: LY83583 stimulated a rapid increase in collagen production by graft SMCs that paralleled the LY83583-induced
increase in superoxide production. The increase in both collagen and superoxide was greater in graft SMCs than aortic
SMCs. Collagen and superoxide production were inhibited by superoxide scavengers. Nicotinamide adenine dinucleotide
phosphate (NADPH) induced significantly more superoxide production by graft SMCs than aortic SMCs, suggesting
that the NADPH oxidase system was more active in graft SMCs. NADPH oxidase inhibitors blocked the superoxide and
collagen production induced by LY83583.
Conclusion: In SMCs, the synthetic phenotype is associated with increased NADPH oxidase activity and elevated
superoxide production in response to an oxidative stress. Superoxide, in turn, leads to increased collagen production.
(J Vasc Surg 2006;43:364-71.)
Clinical Relevance: The inflammatory process after prosthetic vascular graft implantation causes oxidative stress that can
stimulate collagen production by graft SMCs, contributing to the progression of intimal hyperplasia. The exaggerated
response of graft SMCs to oxidative stress offers a potential target for therapeutic interventions.The treatment of vascular and cardiac disease com-
monly uses angioplasty, with or without stenting, or vein or
prosthetic bypass grafts. Vessel patency after these interven-
tions is limited by the frequent development of intimal
hyperplasia, characterized by the accumulation of smooth
muscle cells (SMCs) and extracellular matrix. Factors re-
sponsible for the initiation and propagation of intimal
hyperplasia are not fully elucidated, but contributing fac-
tors may include reactive oxygen species (ROS) and lipid
oxidation products. An arterial injury causes an oxidative
stress,1,2 and elevated superoxide anion (O2
.) production
is detected for several weeks after balloon injury or vein
grafting.2,3 The inflammatory response after arterial injury
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364or bypass grafting produces ROS. In addition, prosthetic
graft material stimulates monocytic cell O2
. production.4
Furthermore, lipid oxidation products accumulate at sites
of arterial injury and in prosthetic grafts5,6 and may con-
tribute to the oxidative stress.
Reactive oxygen species are important in vascular dis-
ease, activating a variety of signaling pathways and inducing
SMC proliferation, altered vascular tone, matrix metallo-
proteinase activation, and lipid oxidation (see references 7
and 8 for review). Common risk factors for atherosclerosis
increase production of ROS,8 and reduced nicotinamide
adenine dinucleotide (NADH) and NADH phosphate
(NADPH) oxidases are a major source of O2
. in the
vascular system.7,9 NAD(P)H oxidases are found in endo-
thelial cells, SMCs, fibroblasts, and macrophages. Intimal
SMCs in hyperplastic and atherosclerotic lesions express
high levels of NAD(P)H oxidase.9,10
Smoothmuscle cellsmodulated to a dedifferentiated phe-
notype, such as the SMCs found on prosthetic grafts, consti-
tutively secretemore collagen type I than do SMCs exhibiting
a contractile phenotype, such as aortic SMCs.11,12 Our previ-
ous studies show that oxidized low-density lipoprotein
(LDL) induces a larger increase in collagen secretion from
graft SMCs than aortic SMCs.12 These studies suggest that
induction of platelet-derived growth factor (PDGF) pro-
duction stimulates the increased collagen synthesis over
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increased collagen. Antibody to PDGF decreases, but
does not eliminate, the oxidized LDL-induction of col-
lagen production. Oxidized LDL also stimulates a small
but significant increase in collagen production by aortic
SMCs12 but no significant increase in PDGF production.13
This suggests that other factors contribute to the in-
crease in collagen secretion after exposure to oxidized
LDL. Jimi et al14 noted increased collagen production by
aortic SMCs exposed to LDL under oxidizing conditions
for 24 hours and inhibition of the increase by antioxidants.
Therefore, we explored differences in collagen production
by graft and aortic SMCs in response to an oxidative stress.
Collagen secretion increased within 3 hours of exposure to
an ROS generator, and the increase was significantly greater
in graft SMCs than aortic SMCs. Investigation of the
mechanism for the observed difference demonstrated that
reducedNAD(P)H. oxidase activitywas significantly higher in
graft SMCs than aortic SMCs, and contributed to increased
O2
. and collagen type I production.
MATERIAL AND METHODS
Graft implantation and removal. Twenty adult fe-
male mongrel dogs underwent implantation of Microvel
double velour Dacron grafts (Boston Scientific, Natick,
Mass), 8 mm internal diameter and 20 to 22 cm in length,
in the thoracoabdominal position as previously de-
scribed.15 The Institutional Animal Care and Use Commit-
tee approved the animal protocol. All procedures and care
complied with the standards stated in the National Insti-
tutes of Health Guide for the Care and Use of Laboratory
Animals (Institute of Laboratory Animal Resources, Com-
mission of Life Sciences, National Research Council, Wash-
ington DC: National Academy Press, 1996). After 18 to 20
weeks, the graft and native aorta were carefully isolated,
flushed with M199 tissue culture medium, and excised en
bloc for cell harvest.
SMC harvest and culture. The graft and aorta were
divided into segments based on location. After removal of
endothelial cells as previously described,13 each section was
finely minced and incubated for 2 hours in M199 contain-
ing 15 U/mL elastase type II (Roche, Indianapolis, IN),
170 Wunsch U/mL collagenase A (Roche), 2 mg/mL
crystalline bovine serum albumin (GibcoBRL; Grand Is-
land, NY), and 0.375 mg/mL soybean trypsin inhibitor
(Roche). After centrifugation at 300g for 5 minutes, cells
were resuspended in M199 and plated in serum-coated
tissue culture wells. SMCs were maintained in M199 with
10% fetal bovine serum (FBS) (Hyclone Laboratories, Lo-
gan, Utah) until confluent, then passaged by trypsinization
and subcultured. SMCs used in this study were isolated
from either the middle of the graft, at least 5 cm removed
from either anastomosis, or from the abdominal aorta, at
least 5 cm removed from the distal anastomosis.
Identity of the SMCs was confirmed by immunohisto-
chemistry as previously described.13 Experiments were per-
formed on passage two and three cells. Comparisons were
made between graft and aortic SMCs from the same animaland the same passage. Multiple studies in our laboratory
have shown no significant differences in collagen produc-
tion by SMCs harvested from the mid graft and from the
graft adjacent to the anastomosis.
SMC studies. For assays, SMCs were grown in
Dulbecco’s modified Eagle’s medium (DMEM) with 10%
FBS in 24-well plates until reaching 80% confluence, then
placed in DMEM with 5% FBS to reduce proliferation.
After 24 hours, DMEM with 5% FBS containing test
agents was substituted. LY83583 (6-anilinoquinoline-5,8-
quinone) (Calbiochem, La Jolla, Calif), which increases
O2
. formation through both enzymatic (NAD[P]H oxi-
dase family) and nonenzymatic pathways,16 was used to
stimulate production of ROS. Enzyme inhibitors or O2
.
scavengers were added to SMCs 30 minutes before
agonists stimulating ROS production. The O2
. scaven-
gers tested included tiron (4,5-dihydroxy-1,3-benzene-
disulfonic acid) (Sigma, St. Louis, Mo), TEMPO (2,2,6,6-
tetramethyl 1-piperidinyloxyl) (Sigma), and o-cresol
(Sigma). Flavin enzyme inhibitors, diphenylene iodonium
(DPI) (Sigma) and hydralazine (Sigma), were used to
inhibit NAD(P)H oxidase. After treatment, media were
collected and assayed for collagen. The cell layer was col-
lected and assayed for total DNA.
Enzyme-linked immunosorbent assay for collagen
type I. The presence of collagen type I in conditioned
medium was quantified by sandwich enzyme-linked immu-
nosorbent assay (ELISA).12 Nunc-immuno 96-well ELISA
plates (Maxisorp, Naperville, Ill) were coated with 0.4
g/well of goat polyclonal antihuman collagen type I
antibody (Southern Biotechnologies, Birmingham, Ala
#1200-01S) for 18 hours at 4°C. Plates were blocked with
3% bovine serum albumin (Sigma) for 1 hour at 37°C, then
100 L aliquots of samples were added and incubated
overnight at 4°C. Monoclonal mouse antihuman collagen
type I antibody (Calbiochem #CP17) was added at 0.02
g/well and incubated at 37°C for 3 hours. Sheep anti-
mouse antibody linked to horseradish peroxidase (Amer-
sham, Buckshire, UK # NA931V) was added for 1 hour at
room temperature. Plates were developed using o-phenyl-
enediamine chromogen substrate (DAKO Cytomation,
Glostrup, Denmark). The reaction was terminated with the
addition of 0.5 M sulfuric acid, and plates were read at 490
nm. Collagen was expressed as ng/g DNA to correct for
potential differences in the number of cells per well.
DNA assay. After removal of conditioned medium for
collagen assay, DNA was quantitated as a measure of SMC
number using the method described by Labarca and Pai-
gen.17 Briefly, SMCs were lysed in 0.1% sodium dodecyl
sulfate in PBS, and DNA was fragmented using a micro-
probe ultrasonic processor for 3 seconds at an amplitude of
40. A 10-L aliquot of cell lysate was diluted with phos-
phate buffer, and an equal volume of bis-benzamide solu-
tion was added. DNA standards were prepared using calf
thymus DNA (Sigma). After 15 minutes, fluorescence was
read by using a FL600 Microplate Reader (BioTek,
Woburn, Mass) with excitation at 360 nm and emission at
d B.
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DNA standard curve.
Superoxide anion detection. Production of O2
. was
assessed by using a lucigenin chemiluminescent assay.18 Qui-
escent SMCs were trypsinized and suspended in phenol-free
Roswell Park Memorial Institute (RPMI) 1640 medium.
SMCs (200,000/well) were placed in 96-well plates and
maintained in a light-free environment at room temperature.
Superoxide anion scavengers and NAD(P)H oxidase inhibi-
tors were added as appropriate. After 30minutes, agonists and
10 mol/L lucigenin (Sigma) were added, and luminescence
was measured immediately by using a Wallac 1420 Victor2
Multilabel Counter (Perkin-Elmer, Boston,Mass). Data were
expressed as counts per seconds.
Statistics. All data represent the mean  SD, unless
otherwise noted. Experiments were performed in triplicate
with at least three different cell isolates. Data evaluation was
performed by t test or analysis of variance using GraphPad
InStat (GraphPad Software, Inc, San Diego, Calif). Differ-
ences were considered statistically significant at P  .05.
RESULTS
Collagen secretion by graft and aortic SMCs. To
determine the effect of ROS on collagen production, graft
and aortic SMCs were incubated with LY83583, a known
Fig 1. Graft smooth muscle cells (SMCs) secrete more
in response to LY83583 (LY). A, Graft and aortic SMC
modified Eagle’s medium (DMEM) with 10% fetal bovin
DMEM with 5% FBS for 24 hours. Medium and cells we
1 mol/L LY83583. Collagen type I present in the m
assay. DNA in the cell layer was quantitated by fluoromet
P  .01 for graft SMCs compared with aortic SMCs at
SMCs at all times after 2 hours, P  .01 for aortic SMC
B, Graft and aortic SMCs (passage 2) were grown as abo
I, and DNA were measured. *P .01 compared with ao
#P  .01 for LY83583-treated aortic or graft SMCs co
graphs of five separate experiments are shown in A anstimulator of ROS production, for times ranging from 1 to48 hours. Graft SMCs secreted significantly more collagen
than aortic SMCs under basal and ROS-stimulated condi-
tions. LY83583 induced a rapid increase in collagen type I
secretion by both aortic and graft SMCs that was signifi-
cantly greater than baseline by 3 hours (Fig 1, A). At 12
hours, the LY83583-treated graft SMCs produced 18.31
0.19 ng collagen/g DNA compared with control graft
SMCs, which secreted 4.74  0.56 ng collagen/g DNA
(P  .01). LY83583-treated aortic SMCs secreted 9.52 
0.22 ng collagen/g DNA in 12 hours compared with
1.99  0.04 ng collagen/g DNA in untreated aortic
SMCs (P .01). Between 12 and 24 hours, collagen in the
conditioned medium of graft and aortic SMCs increased by
approximately 25% and then was relatively stable for up to
48 hours (data not shown).
The responsiveness of SMCs to increasing concentra-
tions of LY83583 was assessed. Under basal conditions,
graft SMCs secreted 7.71  4.14 ng collagen/g DNA
and aortic SMCs secreted 0.34  0.49 ng collagen/g
DNA (P  .01). LY83583 (0.25 mol/L) stimulated
collagen production by both graft and aortic SMCs. After
incubation with 1 mol/L LY83583, graft SMCs secreted
22.23 4.12 ng collagen/gDNA in 12 hours, and aortic
SMCs produced 7.05  1.46 ng collagen/g DNA (P 
en type I than aortic SMCs under basal conditions and
ssage 2) were grown to near confluence in Dulbecco’s
m (FBS). Cells were made quiescent by placing them in
llected at 1, 2, 3, 6, 9, and 12 hours after the addition of
was determined by enzyme-linked immunoabsorbent
say. The collagen type I was standardized to g of DNA.
es, P  .01 for graft SMCs  LY compared with graft
Y compared with aortic SMCs at all times after 2 hours.
t 12 hours after the addition of LY83583, collagen type
MCs at same LY83583 concentration (Student’s t test)
red to untreated aortic or graft SMCs. Representative
Values are expressed as the mean  SD.collag
s (pa
e seru
re co
edium
ric as
all tim
s  L
ve. A
rtic S
mpa.01). Collagen production by graft SMCs was higher than
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stress with increased collagen production.
Production of O2
. by graft and aortic SMCs.
Although both graft and aortic SMCs increased collagen
production in response to the ROS generator, the collagen
secretion by graft SMCs was significantly greater. To deter-
mine if this was a reflection of a difference in ROS produc-
tion, the amount of O2
. secreted by graft and aortic SMCs
in response to LY83583 was measured. Basal O2
. produc-
tion, measured by using the lucigenin assay, was similar in
graft and aortic SMCs (Fig 2). The addition of LY83583
resulted in an immediate increase in O2
. production that
was greater in graft than aortic SMCs (P  .01). The rise
peaked in 20minutes at approximately 3.5 times the level of
control graft SMCs (P  .01) (Fig 2). Aortic SMCs had a
similar but smaller rise, peaking in 16 minutes at approxi-
mately 2.3 times the level of control aortic SMCs (Fig 2).
After peaking, O2
. levels plateaued and remained elevated
even after 50 minutes (P  .01). LY83583 induced a
greater increase in both O2
. and collagen production in
graft SMCs than aortic SMCs. On the other hand, basal
levels of collagen production were higher in graft SMCs
than aortic SMC, despite similar levels of O2
. production.
Effect of O2
. scavengers on collagen secretion. To
determine the role of O2
. in collagen type I production,
SMCs were treated with the O2
. scavengers tiron, TEMPO,
and o-cresol. A 30-minute pretreatment with tiron prevented
the LY83583-induced rise in O2
. production in aortic and
graft SMCs (Fig 3). Pretreatment with tiron also inhibited t h e
LY83583-induced collagen type I secretion by 85% in
aortic and graft SMCs (P  .01) (Fig 3). Tiron is a heavy
Fig 2. Graft smooth muscle cells (SMCs) treated with LY83583
(LY) generate more O2
. than LY83583-treated aortic SMCs.
LY83583 (3 mol/L) and lucigenin (10 mol/L ) were added to
aliquots of 200,000 aortic or graft SMCs (passage 3). Lumines-
cence was measured every 2 minutes. The graph depicts mean 
SEM of counts obtained in four separate experiments. P .01 for
all points after t  0 when comparing either graft SMCs 
LY83583 or aortic SMCs  LY83583 with respective controls.metal chelator as well as a O2
. scavenger. To confirm thatthe effect of tiron was secondary to its O2
. scavenging
property, scavengers with different mechanisms of action
were also tested. TEMPO, a nitroxide that is a metal-
independent O2
. scavenger, had a similar effect on O2
.
and collagen type I as did tiron (data not shown). A third
O2
. scavenger, o-cresol, also inhibited O2
. and collagen
type I production, but this inhibitor was less effective than
the other scavengers, inhibiting both O2
. and collagen
production by 25% (P  .05) (data not shown). Thus, the
effectiveness of the O2
. scavenger correlated closely with
its ability to inhibit the LY83583-induced collagen produc-
tion.
NAD(P)H oxidase activity. Since NAD(P)H oxi-
dases are a predominate source of O2
. within vascular
SMCs, NADPH oxidase activity was assessed in graft and
aortic SMCs bymeasuringO2
. production in the response
to 0.1 mmol/L NADPH (Calbiochem). NADPH in-
creased O2
. production by graft and aortic SMCs in a
time-dependent fashion, peaking by 20 minutes (Fig 4).
The production of O2
. by graft SMCs peaked at 4.5-fold
higher than baseline (P  .01), and O2
. production by
aortic SMCs peaked at 2.5-fold higher than baseline (P 
.01). The production of O2
. by both graft and aortic
SMCs remained 2.5- and 1.5-fold above their respective
baseline 40 minutes after NADPH treatment (P  .01).
NADPH oxidase activity, as measured by O2
. generation,
was approximately twofold higher in graft SMCs than
aortic SMCs (P  .01) at 22 minutes after the addition of
LY83583. Pretreatment with DPI, an effective NADPH ox-
idase inhibitor, eliminated the NADPH-induced rise in O2
.
production by graft and aortic SMCs (P  .01) ( Fig 4). These
findings suggest that NADPH oxidase activity is higher in
graft than aortic SMC.
Effect of NAD(P)H oxidase inhibition on LY83583-
induced O2
. production and collagen secretion. The
role of NAD(P)H oxidase in LY83583-induced O2
. pro-
duction by graft and aortic SMCs was assessed by using the
NAD(P)H oxidase inhibitors hydralazine and DPI.19,20
Hydralazine, DPI, or hydralazine and DPI combined,
added 30 minutes before and during incubation with
LY83583, inhibited 60%, 80%, and 95%, respectively, of the
LY83583-induced O2
. production by graft SMCs (P 
.01), and 40%, 70%, and 85%, respectively, by aortic SMCs
(P  .01). There was no significant difference in O2
.
generation by graft and aortic SMCs incubated with
LY83583 when SMCs were pretreated with hydralazine
and DPI (Fig 5, A).
Because DPI and hydralazine effectively blocked the
LY83583-induced O2
. production, the ability of these
inhibitors to reduce LY83583-stimulated collagen secre-
tion was assessed (Fig 5, B). Pretreatment with DPI re-
sulted in 80% to 85% inhibition of LY83583-induced col-
lagen type I secretion from graft and aortic SMCs, whereas
hydralazine decreased collagen secretion by 40% to 50% (P
 .01). Inhibition of NAD(P)H oxidase by the combina-
tion of DPI and hydralazine reduced collagen type I secre-
tion to baseline levels for both aortic and graft SMCs. The
inhibition of LY83533-induced collagen production seen
cont
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hydralazine paralleled the inhibition of O2
. production,
suggesting that NAD(P)H oxidase-generated O2
. played
a role in collagen type I regulation. Interestingly, DPI
alone, but not hydralazine alone, consistently induced a
small increase in collagen production by graft and aortic
Fig 3. Scavenger of O2. inhibits collagen type I secretion
Confluent aortic SMCs were placed in medium containing 5
suspended inphenol-freeRoswell ParkMemorial Instituteme
mmol/L tiron was added for 30 minutes before and during
Methods and depicted as the fold increase (mean SD) in cou
B,AorticSMCs(passage3)weregrowntonear confluenceand
with 1.5 mmol/L tiron for 30 minutes before and during i
mediumwas collected and the cells were harvested tomeasure
SMCs were incubated with 3 mol/L LY83583 with or w
described in A. D, Graft SMCs (passage 3) were grown to n
described inB.A andC are representative of 3 separate experim
In A and C, P .01 at all time points after t 0 comparing
SMCs with tiron. InB andD, *P .01 when compared withSMCs, the cause of which is unknown.DISCUSSION
Smooth muscle cell phenotype has a profound influ-
ence on function, including protein synthesis. Collagen
secretion by dedifferentiated SMCs is significantly higher
than SMCs in a contractile state.21 SMCs cultured from
ooth muscle cells (SMCs) treated with LY83583 (LY). A,
al bovine serum (FBS) for 24 hours. SMCs (200,000) were
and incubatedwith3mol/LLY83583. Inparallelwells, 1.5
583 treatment. Luminescence was measured as described in
r second compared with respective untreated SMCs at t 0.
d inmediacontaining5%FBSfor24hours.Cellswere treated
tion with 1 mol/L LY83583 as indicated. After 9 hours,
NA.Collagen type Iwas normalized togofDNA.C,Graft
1.5 mmol/L tiron, and O2
. production was measured as
nfluence and treated in an identical fashion to aortic SMCs
,B andD are representative graphs of 5 separate experiments.
583-treated SMCs with control SMCs or LY83583-treated
rol.in sm
% fet
dium
LY83
nts pe
place
ncuba
theD
ithout
ear co
ents
LY83prosthetic grafts exhibit a dedifferentiated or synthetic
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collagen than SMCs cultured from the aorta, which retain a
differentiated or contractile phenotype for several pas-
sages.12,13 Dedifferentiated SMCs from diabetic rat aortas
or vein grafts produce higher levels of O2
. than control
SMCs.10,22
We do not find a difference in basal O2
. production by
graft and aortic SMCs, so this is not the mechanism of the
elevated basal collagen secretion by graft SMCs. Further-
more, DPI or hydralazine do not decrease basal levels of
collagen production by graft SMCs to that of aortic SMCs,
again suggesting that a mechanism other than O2
. pro-
duction by NAD(P)H oxidase is responsible. On the other
hand, stimulation by NADPH causes a greater increase in
O2
. production by graft SMCs than aortic SMCs, suggest-
ing increased NADPH oxidase activity. After arterial injury,
the expression of NAD(P)H oxidase catalytic components,
nox1 and nox4, is increased in SMCs.23 Phenotypic mod-
ulation of SMCs resulting in the altered expression of
NADPH oxidase components could explain the difference
in the time course of superoxide production in graft and
aortic SMCs. Further studies are required to explore this
Fig 4. Nicotinamide adenine phosphate dinucleotide (NADPH)
oxidase activity is higher in graft smooth muscle cells (SMCs) than in
aortic SMCs. Graft and aortic SMCs (passage 3) were harvested and
suspended in phenol-free Roswell Park Memorial Institute medium.
Aliquots of 200,000 graft or aortic SMCs were incubated with 0.1
mmol/L NADPH or solvent control. In parallel wells, SMCs were
treated with 2 mol/L diphenylene iodonium (DPI) for 30 minutes
before and during incubation with NADPH. Luminescence was
measured as described inMethods, and depicted as fold increase (mean
 SD) in counts per second compared with respective untreated
SMCs at t 0 (n 3 separate experiments). P .01 at all times after
t  0 for NADPH-treated graft or aortic SMCs compared with
respective controls or NADPH-treated SMCs pretreated with DPI.possibility.Reactive oxygen species can cause phenotypic modula-
tion of SMCs. Transfection of NIH3T3 cells with mox1
increases O2
. production and causes cells to lose contact
inhibition and exhibit a transformed appearance.24 Many of
the risk factors for atherosclerosis cause increased O2
.
production, and oxidative stress may induce the SMC
dedifferentiation that is an early event in atherogenesis and
the development of intimal hyperplasia. The role of ROS in
phenotype modulation, however, is difficult to separate
from the role of phenotype in ROS production. We specu-
late that SMC phenotype is modulated as part of the
response to the injury of graft implantation, perhaps as a
result of the increased O2
. production that accompanies
inflammation. One of the manifestations of the phenotypic
modulation is elevated ROS production.
Arterial injury is accompanied by an inflammatory re-
sponse and increased production of ROS by arterial wall
cells. NAD(P)H oxidase is an important source of O2
.
after arterial injury and in vein grafts.3,10,23,25,26 Balloon
injury causes increased NAD(P)H oxidase activity with
elevated O2
. production within 24 hours,25 and O2
.
production by injured vessels remains elevated 14 days after
injury.2 The messenger RNAs (mRNAs) for NAD(P)H
oxidase subunits found in SMCs are elevated from days 3
through 15 after injury.23 The ability of DPI to inhibit
the high O2
. production by vein grafts suggests that
NAD(P)H oxidases are the source of the O2
. in vein grafts
as well as arterial injuries.3 The NAD(P)H oxidase protein
and activity are localized to the dedifferentiated intimal
SMCs in the vein grafts, and the increased O2
. production
is an important signal for proliferation.10
Increased NAD(P)H oxidase activity may contribute to
the development of intimal hyperplasia by stimulating SMC
proliferation,10 but our study suggests that NAD(P)H
oxidase activity also induces collagen deposition in areas of
arterial injury or anastomotic intimal hyperplasia. The pat-
tern of NAD(P)H oxidase subunit mRNA expression after
an arterial injury suggests that theNAD(P)H oxidasemight
be associated with matrix deposition.23
The effect of oxidative stress on collagen synthesis
varies with the cell type. In cardiac fibroblasts, oxidative
stress decreases the expression of procollagen 1(I), 2(I),
and 1(III) mRNA and collagen synthesis at 24 hours and
increases matrix metalloproteinases activity.27 In fetal hu-
man fibroblasts, on the other hand, O2
. stimulates colla-
gen production,28 and antioxidants decrease the basal level
of collagen gene expression.29 Oxidative stress also stimu-
lates collagen synthesis in rat aorta in vivo.30 Our results
clearly show the ROS increase collagen production in both
aortic and graft SMCs. The agonist-stimulated increase in
O2
. and collagen production is greater in the dedifferen-
tiated graft SMCs than contractile aortic SMCs.
The effect of ROS on collagen could result from in-
creased production or decreased degradation. New protein
synthesis is required for this effect, as demonstrated by
cycloheximide and metabolic labeling studies (data not
shown), but the rapid increase in collagen in the condi-
tioned medium could result from a dramatic inhibition of
ctive
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activate matrix metalloproteinases in SMCs.31-33 In fact,
mechanical stretch of SMCs induces ROS formation via
NAD(P)H oxidase that in turn increases matrix metallo-
proteinase-2 mRNA and proenzyme release.32
The role of ROS in stimulating collagen production
suggests that O2
. scavengers or NAD(P)H oxidase inhib-
itors could inhibit collagen secretion and limit intimal
hyperplasia. Several experimental studies support this
premise. The antioxidants probucol and N-acetylcysteine
reduce intimal thickening after arterial balloon injury,34-38
and probucol’s effect is independent of its lipid-lowering
properties. Intraoperative superoxide dismutase treatment
decreases intimal hyperplasia in experimental vein grafts,39
supporting our premise of a causal role for O2
.. Angioten-
sin II receptor antagonists, which decrease NAD(P)H ox-
idase production of superoxide in SMCs, reduce intimal
hyperplasia in experimental vein grafts.40 The effect of
antioxidants on collagen production, specifically, has not
been reported, but our findings in vitro suggest that these
agents would inhibit collagen deposition in vivo, contrib-
uting to the reduction of hyperplastic lesions.
CONCLUSION
Our studies show that oxidative stress induces a greater
increase in collagen type I secretion by graft SMCs than by
Fig 5. Inhibition of nicotinamide adenine (phosphate)
induced O2
. and collagen type I production by aortic an
(DPI) (2 mol/L) and 100 mol/L hydralazine (H) wer
LY83583 (3 mol/L) treatment. Production of O2
. was
Methods and depicted as fold increase (mean SD) in coun
0 (n 3 separate experiments). P .01 for all time points w
SMCs pretreated with DPI and hydralazine. B, SMCs (pa
treated with 2 mol/L DPI and/or 100 mol/L hydrala
with 1 mol/L LY83583 for 9 hours. Conditioned mediu
immunoabsorbent assay. SMCs were lysed and DNA meas
micrograms of DNA. Representative graph of five separat
under the same conditions, #P .01 compared with respeaortic SMCs as a result of higher NAD(P)H oxidase activityin graft SMCs. The increase in collagen type I secretion
parallels the increase in O2
. production in both the graft
and aortic SMCs. Superoxide anion scavengers abrogate
the increase in collagen secretion, supporting the premise
that O2
. is responsible for the early increase in collagen
type I production. Inhibition of NAD(P)H oxidase using
DPI and hydralazine decreases bothO2
. and collagen type
I production. Our findings suggest that NAD(P)H
oxidase-mediated O2
. production may be important in
the increased collagen deposition that is a hallmark of
intimal hyperplasia, and this provides an opportunity for
mechanism-based therapy to inhibit intimal hyperplasia.
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